Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
: 4 years No. of scholarships: 5 Coordinator: Prof. Carlo Rescigno Contact e-mail: acma@ssmeridionale.it 2. Clinical and Translational Oncology (CTO) Program duration: 4 years No. of scholarships: 5
-
the following documents to the attention of EBRI Scientific Director, Prof. Enrico Cherubini, via email at: scientific.assist@ebri.it A one-page cover letter, a curriculum vitae, list of publications, a short
-
development. With over 18,000 students and a strong international community, CZU is a dynamic and modern institution committed to excellence in research, innovation, and education. CZU consistently ranks among
-
emphasis on exciting biomedical projects at the interface of chemistry and biology. The successful candidate is a creative personality with a competitive research program that will take full advantage
-
bonuses • Opportunities for professional growth of the highest level Sentcell LTD was founded by Prof. Dr Alessio Lanna in the UK back in 2019, and has rapidly been recognised at the top of all biotech
-
field of Mathematics and will be pursued through a "direct call" procedure. The Direct Calls program of the Italian Ministry of Research (MUR) offers funding for academic positions to scientists and
-
should have a strong track record of scientific accomplishments with international recognition. We seek an outstanding investigator to join our research center with a focus on developing new devices
-
. Development Financial Support: Annual salary of 90 million KRW, including legal contributions (e.g., 4 major insurances). Research Funding: Opportunity for concurrent participation in other projects and
-
in cancer treatment, i.e. protein/antibody engineering, adoptive T cell therapy, CAR T cells, etc. Humanitas Research center is equipped with newly developed laboratories and a wide range of state
-
, interdisciplinary research environment. Upon successful evaluation, the appointment may be extended. Your Role You will develop and lead a cutting-edge research program focused on immune mechanisms in